| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111287 Acetylated protein |
| 05/25/2006 | US20060111274 Methods and compositions for enhancing transport across biological membranes |
| 05/25/2006 | US20060110790 Expression system for large functional proteins |
| 05/25/2006 | US20060110770 Administering polypeptide of given sequence, which hydrolyzes DNA in sputum of cystic fibrosis patients |
| 05/25/2006 | US20060110769 Regulation of novel human prolyl 4-hydroxylases |
| 05/25/2006 | US20060110766 Method of determining a cellular response to a biological agent |
| 05/25/2006 | US20060110736 Hiv vaccine formulations |
| 05/25/2006 | US20060110730 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/25/2006 | US20060110440 Method and system for biasing cellular development |
| 05/25/2006 | US20060110410 Recombinant toxin fragments |
| 05/25/2006 | US20060110403 Non-human herpesviruses as vectors |
| 05/25/2006 | US20060110398 DAP-10 and uses thereof |
| 05/25/2006 | US20060110397 Protein of given amino acid sequence; yeast-two-hybrid assay screening for agent which inhibits formation of heterodimer and gene expression; diagnosis and treatment of cancer |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110390 Inhibition of Ku as a treatment for cardiovascular diseases |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110377 Immunologically privileged cells and uses thereof |
| 05/25/2006 | US20060110376 MDA-7 and free radicals in the treatment of cancer |
| 05/25/2006 | US20060110375 Method for producing cell lines and organs by means of differentiable cells |
| 05/25/2006 | US20060110364 Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors |
| 05/25/2006 | US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/25/2006 | US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/25/2006 | US20060110359 Cellular delivery of natriuretic peptides |
| 05/24/2006 | EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659176A1 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 05/24/2006 | EP1659175A1 Alterations in seborrheic keratoses and their applications |
| 05/24/2006 | EP1658367A2 Nucleic and protein sequences from the hxhv virus and uses thereof |
| 05/24/2006 | EP1658307A2 Methods for the early diagnosis of ovarian cancer |
| 05/24/2006 | EP1658304A2 Influenza therapeutic |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/24/2006 | EP1610612A4 Endosomolytic polymers |
| 05/24/2006 | EP1471944B1 Pharmaceutical composition which improves in vivo gene transfer |
| 05/24/2006 | EP1423418B1 Mutated env gene, mutated env glycoprotein and the use thereof |
| 05/24/2006 | EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 05/24/2006 | EP1017836B1 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 05/24/2006 | EP1002075B1 Adipocyte-specific protein homologs |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 05/24/2006 | CN1777680A Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 05/24/2006 | CN1777678A Method of treating ischemic disease |
| 05/24/2006 | CN1777672A Recombinant virus comprising tumour therapeutic full-antibody gene with human constant region and its use |
| 05/24/2006 | CN1777622A Modulation of the poliovirus receptor function |
| 05/24/2006 | CN1777448A Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| 05/24/2006 | CN1777447A Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 05/24/2006 | CN1775952A New use of high-expressed human portein in androgen dependent/non-dependent prostatic cancer for prostatic tumour diagnosis and therapeutic prognosis |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775226A Use of attenuated salmonella carraying human PF4 gene for chemotherapeutic protection and hematopoietic reconstitution |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1256986C Production and transferring of protein |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049302 A saponin possessing immune adjuvant activity, derived from Quillaja saponaria; an immunostimulatory oligonucleotide cotaining an unmethylated CpG dinucleotide,wherein the immunostimulatory oligonucleotide is not a part of a DNA vaccine vector |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049144 Polymerizing in presence of drug/nucleic acid/DNA without modifying; for genetic transfer/expression in cells; drug delivery |
| 05/23/2006 | US7049143 Derived from the murine leukemia virus, comprises elongation factor-alpha; for gene therapy |
| 05/23/2006 | US7049142 Gene expression with covalently modified polynucleotides |
| 05/23/2006 | US7049136 Redirection of cellular immunity by receptor chimeras |
| 05/23/2006 | US7049133 Nucleotide sequences for use in regulation of transcription in eukaryotes |
| 05/23/2006 | US7049132 retroviral expression vector, G1NaGRPTK; controlled release and liposomal formulations; freeze dried and unit dosage forms; gene therapy; anticarcinogenic and antidiabetic agents; side effect reduction; genetic engineering of transgenic animals |
| 05/23/2006 | US7049128 For therapy of vascular inflammation and other vascular disorders associated with platelet activation |
| 05/23/2006 | US7049123 Deoxyribonuclease, gene encoding same and use thereof |
| 05/23/2006 | US7049121 For therapy of cocaine-induced condition; cocaine hydrolysis activity |
| 05/23/2006 | US7049118 isolated and purified protein and complimentary DNA; culturing a host cell to express the regulatory protein; biodrugs; enzyme inhibitors; anticarcinogenic, antidiabetic agents; nervous system disorders; chronic obstructive pulmonary disorder |
| 05/23/2006 | US7049117 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/23/2006 | US7049075 Deoxyribonuclease IIβ proteins and cDNAs |
| 05/23/2006 | US7048923 Antibodies to mitogenic oxygenases |
| 05/23/2006 | US7048920 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/23/2006 | CA2201865C Laminin chains: diagnostic and therapeutic use |
| 05/18/2006 | WO2006053315A2 Methods and compositions for treating cellular proliferative diseases |
| 05/18/2006 | WO2006053201A2 Treatment of cancer by simultaneous inhibition of b-raf and restoration or mimicry of p16 ink4a activity |
| 05/18/2006 | WO2006053130A2 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 05/18/2006 | WO2006053090A2 Synergistic inhibition of vegf and modulation of the immune response |
| 05/18/2006 | WO2006053014A2 Selective inhibition of rock1 in cardiac therapy |
| 05/18/2006 | WO2006052960A2 METHODS AND COMPOSITIONS FOR INCREASING STEM CELL HOMING USING Gαs ACTIVATORS |
| 05/18/2006 | WO2006052900A2 Targeted innate immunity |
| 05/18/2006 | WO2006052854A2 Syntheses of polyamine conjugates of small interfering rnas (si-rnas) and conjugates formed thereby |
| 05/18/2006 | WO2006052826A2 Methods for preparing cells and viruses |
| 05/18/2006 | WO2006052790A2 Biodegradable linkers for molecular therapies |
| 05/18/2006 | WO2006052735A2 Fibulin-3 and uses thereof |
| 05/18/2006 | WO2006052649A2 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| 05/18/2006 | WO2006051757A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy |
| 05/18/2006 | WO2006051545A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | WO2006050999A2 Methods of reducing body fat |
| 05/18/2006 | WO2006029161A3 Cell specific gene silencing using cell-specific promoters in vitro and in vivo |
| 05/18/2006 | WO2005118840A3 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10) |
| 05/18/2006 | WO2005117941A3 Methods and compositions for the treatment of polycystic diseases |
| 05/18/2006 | WO2005113013A3 Compositions of ndv and methods of use thereof for treatment of cancer |
| 05/18/2006 | WO2005100392A3 Treatment of neuropathic pain with zinc finger proteins |
| 05/18/2006 | WO2005089268A3 Compositions and methods for optimizing cleavage of rna by rnase h |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | WO2005012407A3 Polymer encapsulation of adenoviruses |
| 05/18/2006 | WO2005007623A3 Inhibition of syk kinase expression |